相关实验视频
Updated: Jul 11, 2025

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
与血红蛋白病变相关的C2H2指转录因子
Xing Zhang1, Fangfang Xia1, Xiaotian Zhang2
1Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
胎儿血球蛋白 (HbF) 表达可以治疗β-血球蛋白乱. 克里斯普尔屏幕识别了控制HbF水平的C2H2指蛋白和DNMT1等调节器,提供治疗潜力.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 状细胞疾病和β-thalassemia源于β-环球蛋白基因缺陷.
- 增加胎儿球蛋白 (HbF) 表达可以改善这些疾病的症状.
- 识别HbF基因表达的调节者对于治疗开发至关重要.
研究的目的:
- 为了确定胎儿全球蛋白 (HbF) 基因表达的新型调节者.
- 探索候选监管机构在调节HbF水平方面的作用,以满足潜在的治疗应用.
- 讨论这些发现对治疗β-血红蛋白疾病的影响.
主要方法:
- 利用CRISPR-Cas9选,针对大约1500个特定序列的DNA结合蛋白.
- 在表达成年血红蛋白的人类红状腺细胞系中进行了查.
- 分析了包括NuRD复合蛋白,C2H2指蛋白,其他转录因子和DNMT1.1在内的已识别的候选调节剂.
主要成果:
- 确定了四组候选HbF基因表达调节剂:NuRD复合蛋白,七种C2H2指蛋白 (包括已知的沉声器ZBTB7A和BCL11A),其他转录因子和DNMT1.
- C2H2指蛋白因其诱导HbF表达的潜力而受到重视.
- 讨论了DNMT1在维护DNA甲基化中扮演的角色,该DNA甲基化会招募NuRD复合体.
结论:
- 克里斯普尔-Cas9屏幕成功识别了HbF基因表达的关键调节者.
- C2H2指蛋白和DNMT1代表了治疗策略的有希望的目标.
- 小分子疗法的进步为调节血红蛋白开关提供了治疗β-血红蛋白疾病的潜力.
更多相关视频
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
07:55Author Spotlight: Exploring Cellular Zinc Regulation Through ZnT1 Functionality
Published on: June 2, 2023
相关概念视频
General Transcription Factors
Transcription Factors
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Master Transcription Regulators
Globular and Fibrous Proteins
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...
Multiple Allele Traits